Advertisement

Topics

TC BioPharm Selected For EU Horizon 2020 Funding To Progress Novel, Mass-Market Cell Therapies To Clinical Trial

20:00 EDT 1 Aug 2017 | BioSpace

4million grant would allow Scottish company to develop next-generation cancer therapies for multiple tumour types Funding represents the largest EU-award to any UK company for development of a healthcare therapeutic product SCOTLAND 2 August 2017 TC BioPharm (TCB) today announced it has been selected for funding from the European Union's Horizon 2020 (H2020) re...

Original Article: TC BioPharm Selected For EU Horizon 2020 Funding To Progress Novel, Mass-Market Cell Therapies To Clinical Trial

NEXT ARTICLE

More From BioPortfolio on "TC BioPharm Selected For EU Horizon 2020 Funding To Progress Novel, Mass-Market Cell Therapies To Clinical Trial"

Quick Search
Advertisement
 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...